DaVita
DVA
#1723
Rank
NZ$21.36 B
Marketcap
NZ$332.89
Share price
-3.01%
Change (1 day)
61.06%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$21.72

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$22.16. In 2025 the company made an earnings per share (EPS) of NZ$17.97 a decrease over its 2024 EPS that were of NZ$19.58.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$21.7220.9%
2025NZ$17.97-8.25%
2024NZ$19.5844.94%
2023NZ$13.5127.26%
2022NZ$10.62-35.56%
2021NZ$16.4844.1%
2020NZ$11.4319.7%
2019NZ$9.55540.48%
2018NZ$1.49-76.07%
2017NZ$6.23-19.31%
2016NZ$7.72242.52%
2015NZ$2.25-62.87%
2014NZ$6.0713.43%
2013NZ$5.358.45%
2012NZ$4.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$44.08 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$21.61-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$46.37 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.76-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA